Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASP.L Regulatory News (ASP)

  • There is currently no data for ASP

Acquisition

30 Jun 2006 07:03

Ascribe plc30 June 2006 Ascribe plc ("Ascribe" or "the Group") Ascribe acquires Patient Administration System ("PAS") supplier HE Information Systems Limited ("HEIS") for £6.492 million Ascribe (AIM:ASP), the health IT Group, today announces further expansion oftheir offering with the acquisition of HE Information Systems, the supplier ofthe CaMIS clinical and information management system to the UK National HealthService. HEIS provides software to 21 hospitals within the NHS, many of whichalso use Ascribe's Pharmacy or Accident & Emergency systems. The total consideration of £6.492 million is to be satisfied by: • On completion - £2.994m of cash - £0.998m to be satisfied by the issue of 3,326,666 shares in the ordinary capital of Ascribe • Deferred for up to 3 years - £1.25m of cash - £1.25m to be satisfied by the issue of shares in the ordinary capital of Ascribe In the year ended 31 March 2005, HEIS made a profit before tax of £0.52m on aturnover of £2.5m. The value of the net assets being acquired is estimated atapproximately £1.15 million. The Board expects that this acquisition will beearnings enhancing during the first year. This acquisition marks a step change for the Group. The HEIS "PAS" productprovides a strategic offering in the Patient Administration System "PAS" andsecondary care, electronic patient record "EPR" markets. The management willjoin the Ascribe team, allowing the Group to restructure its efforts in linewith the opportunities offered by the delays in the National Programme. Due to personal circumstances, Graham Lewis will resign from the Board witheffect from 31 July 2006. The Board wishes him well for the future. StephenCritchlow will assume the role of CEO and Chairman as the Board focuses onconsolidating the Group and optimising the management team with some keyadditions coming from HEIS. Ascribe recently issued a positive trading update and is pleased to report thattrading continues to be in line with expectations. Ascribe has today applied to AIM for admission of the 3,326,666 initialconsideration shares, which is expected to become effective on Thursday 6 July2006. Commenting, Stephen Critchlow, Executive Chairman of Ascribe, said: "Thisacquisition positions Ascribe firmly as a leading health IT solutions provideracross primary and secondary care. HEIS has an excellent and highlycomplementary product and will also bring a strong, experienced management teamto the Group. We will now be able to drive organic growth from a completeproduct set created from best of breed applications. Any future acquisitionswill only follow once the Group is aligned to this significant opportunity." Contacts: Stephen Critchlow, Executive ChairmanTel: +44(0) 161 280 8080Email: stephen.critchlow@ascribe.com Ginny Pulbrook / Justin Griffiths, Citigate Dewe RogersonTel: +44 (0) 20 7638 9671 About Ascribe plc: Ascribe plc is a leading healthcare company that develops and markets softwaresolutions supporting patient, clinical and business processes to theinternational healthcare market. The Group provides solutions to Emergency andMinor Injuries units, Mental Health and Social Care units, Hospitals requiringpatient administration systems (PAS) and medical equipment management, Hospitaland Retail Pharmacies, and General Practice surgeries. Ascribe plc was floated on AIM in 2004, and currently employs 170 personnelthough its five operating companies in the UK, Hong Kong, Kenya, Australia andNew Zealand. For more information, please visit www.ascribe.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 20219:49 amRNSUpdate on TIDM Code
1st Jun 20217:00 amRNSAdmission to Main Market
27th Jan 200911:45 amRNSPosting of re-registration circular
21st Jan 20097:30 amRNSOffer Unconditional in all Respects
8th Jan 20097:00 amRNSOffer update
7th Jan 20091:14 pmRNSHolding(s) in Company
5th Jan 20096:08 pmRNSGeneral Meeting & Recommended Cash Offer
18th Dec 20083:55 pmRNSAnnual Report and Accounts
17th Dec 20088:00 amRNSRecommended Cash Offer
10th Dec 200812:42 pmRNSResult of AGM
17th Nov 20087:00 amRNSDirector/PDMR Shareholding
10th Oct 200810:45 amRNSRule 8.3- Ascribe PLC
3rd Oct 200812:09 pmRNSRule 8.3- Ascribe PLC
1st Oct 20087:00 amRNSFinal Results
26th Sep 20087:00 amRNSAcquisition
3rd Sep 20089:06 amRNSExercise of Options
21st Aug 200811:39 amRNSRule 8.3- Ascribe Plc
19th Aug 20088:19 amRNSAnnouncement regarding possib
22nd Jul 20087:00 amRNSTrading Update
8th May 20087:01 amRNSASCC Framework Agreement
14th Apr 20084:29 pmRNSHolding(s) in Company
2nd Apr 20088:00 amRNSInstallement of Web Pharmacy
12th Mar 20087:01 amRNSInterim Results
15th Feb 20082:55 pmRNSIssue of Equity
4th Feb 20089:57 amRNSIssue of Equity
23rd Jan 20087:01 amRNSTrading Statement
21st Jan 20084:54 pmRNSIssue of Equity
7th Dec 200711:23 amRNSHolding(s) in Company
6th Dec 20075:28 pmRNSHolding(s) in Company
29th Nov 200711:29 amRNSDirector/PDMR Shareholding
31st Oct 200711:23 amRNSTrading update &Result of AGM
29th Oct 20073:24 pmRNSHolding(s) in Company
26th Oct 200711:29 amRNSHolding(s) in Company
25th Oct 20074:06 pmRNSDirector/PDMR Shareholding
25th Oct 200711:31 amRNSIssue of Equity
22nd Oct 20071:35 pmRNSIssue of Equity
22nd Oct 200712:40 pmRNSAcquisition
5th Oct 20079:09 amRNSHolding(s) in Company
25th Sep 20072:50 pmRNSHolding(s) in Company
19th Sep 20077:01 amRNSFinal Results
4th Sep 20077:00 amRNSNotice of Results
17th Aug 20075:30 pmRNSAIM Rule 26
17th Aug 20074:53 pmRNSAIM Rule 26 Information
15th Aug 20072:00 pmRNSHolding(s) in Company
9th Aug 20075:57 pmRNSHolding(s) in Company
30th Jul 20072:40 pmRNSIssue of Equity
24th Jul 20077:00 amRNSTrading Update
16th Jul 20075:19 pmRNSHolding(s) in Company
16th Jul 20077:00 amRNSDirectorate Change
8th Jun 20072:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.